{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:26:12Z","timestamp":1792783572671,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Blavatnik Biomedical Accelerator"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI109740"],"award-info":[{"award-number":["U19AI109740"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.antiviral.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T11:24:02Z","timestamp":1550057042000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Identification of small molecule inhibitors targeting the Zika virus envelope protein"],"prefix":"10.1016","volume":"164","author":[{"given":"Jared","family":"Pitts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yun","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Philipp","family":"Pfeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-8011","authenticated-orcid":false,"given":"Zhengnian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaebong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael S.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-2557","authenticated-orcid":false,"given":"Priscilla L.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.02.008_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.02.008_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12879-018-2965-4","article-title":"Study on the persistence of Zika virus (ZIKV) in body fluids of patients with ZIKV infection in Brazil","volume":"18","author":"Calvet","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.02.008_bib3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.02.008_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chembiol.2016.03.010","article-title":"GNF-2 inhibits dengue virus by targeting Abl kinases and the viral E protein","volume":"23","author":"Clark","year":"2016","journal-title":"Cell. Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.02.008_bib5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.chembiol.2018.05.011","article-title":"Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein","volume":"25","author":"de Wispelaere","year":"2018","journal-title":"Cell. Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.02.008_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01559-15","article-title":"Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing","volume":"6","author":"Dowd","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.02.008_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","article-title":"Maternally acquired Zika antibodies enhance dengue disease severity in mice","volume":"24","author":"Fowler","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.02.008_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.02.008_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature20556","article-title":"Zika virus infection damages the testes in mice","volume":"540","author":"Govero","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.02.008_bib10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.02.008_bib11","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/infdis\/jiw340","article-title":"Critique of World Health Organization recommendation of a dengue vaccine","volume":"214","author":"Halstead","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.02.008_bib12","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.vaccine.2016.02.004","article-title":"Protective and immunological behavior of chimeric yellow fever dengue vaccine","volume":"34","author":"Halstead","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.02.008_bib13","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika virus infection in human skin cells","volume":"89","author":"Hamel","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.02.008_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"533","author":"Kostyuchenko","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.02.008_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1021\/acsinfecdis.8b00127","article-title":"Discovery of immunologically inspired small molecules that target the viral envelope protein","volume":"4","author":"Lian","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.02.008_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2018.12.016","article-title":"Dengue drug discovery: progress, challenges and outlook","volume":"163","author":"Lim","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2019.02.008_bib17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.cell.2016.11.016","article-title":"Zika virus causes testis damage and leads to male infertility in mice","volume":"167","author":"Ma","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.02.008_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.02.008_bib19","unstructured":"Pan-American Health Organization\/World Health Organization Zika Report https:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=11599:regional-zika-epidemiological-update-americas&Itemid=41691&lang=en."},{"issue":"13","key":"10.1016\/j.antiviral.2019.02.008_bib20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1613108","article-title":"Persistence of Zika virus in body fluids - preliminary report","volume":"379","author":"Paz-Bailey","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.02.008_bib21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/acscentsci.8b00494","article-title":"pH dependence of Zika membrane fusion kinetics reveals an off-pathway state","volume":"4","author":"Rawle","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.antiviral.2019.02.008_bib22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.02.008_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.02.008_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002627","article-title":"Small-molecule inhibitors of dengue-virus entry","volume":"8","author":"Schmidt","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.02.008_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.02.008_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.02.008_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20021840","article-title":"DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells","volume":"197","author":"Tassaneetrithep","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.02.008_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.02.008_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chom.2018.10.008","article-title":"Cross-reactive dengue virus antibodies augment Zika virus infection of human placental macrophages","volume":"24","author":"Zimmerman","year":"2018","journal-title":"Cell Host Microbe"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218307654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218307654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T14:44:53Z","timestamp":1565189093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218307654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"alternative-id":["S0166354218307654"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of small molecule inhibitors targeting the Zika virus envelope protein","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}